All hype, no research During CBC's undercover consultation, Seit admitted there was a lack of clinical human studies on BPC-157
Mechanism and Side Effects of IGF-1 LR3 Aug 12022 IGF-1 LR3 is a synthetic protein and lengthened analogue of human insulin-like growth factor 1 (IGF-1).It differs from native IGF-1 in that it possesses an arginine instead of a glutamic acid at the third position in its amino acid sequence ("arginine 3"), and also has an additional 13 amino acids at its N-terminus (MFPAMPLLSLFVN) ("long"), for a total of 83 amino acids (relative to the 70 of IGF-1).The consequences of these modifications are that IGF-1 LR3 retains the pharmacological activity of IGF-1 as an agonist of the IGF-1 receptor, has very low affinity for the insulin-like growth factor-binding proteins (IGFBPs), and has improved metabolic stability
As I discuss here, neutralization may even make a non-decisive contribution to the in vivo efficacy of antibodies that are described as neutralizing in vitro
8 weeks: 1-2 vials use 3-6 mL total
Most hair problems on GLP-1 drugs come from sudden changes in intake, not from the molecule itself
Yes, it is possible to overdose on Ozempic